IBBQ stock forecast, quote, news & analysis

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL).

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

The average market capitalization across the Invesco Nasdaq Biotechnology ETF ETF is 6.85B. The market cap for tickers in the group ranges from 16.66M to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is MRNS at 16.66M.

The average weekly price growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was -10%. For the same ETF, the average monthly price growth was -9%, and the average quarterly price growth was -1%. TSHA experienced the highest price growth at 37%, while RAPT experienced the biggest fall at -62%.

The average weekly volume growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 13%. For the same stocks of the ETF, the average monthly volume growth was 71% and the average quarterly volume growth was 82%